Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple therapy vs Avastin in neovascular AMD
NCT00464347Phase 2Terminated
- Sponsor
- National Eye Institute
- Start
- Jan 2007
- Modality
- Orthosteric Ligands, Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of triamcinolone acetonide, verteporfin in neovascular age-related macular degeneration (NVAMD), sponsored by National Eye Institute. Started Jan 2007; status: terminated.
02
Drugs
triamcinolone acetonideverteporfin
03
Conditions
neovascular age-related macular degeneration (NVAMD)
Beyond the preview
Go deeper on NCT00464347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00464347.